APTTP - Overview: Activated Partial Thromboplastin Time, Plasma
Monitoring heparin therapy (unfractionated heparin) Screening for certain coagulation factor deficiencies Detection of coagulation inhibitors such as lupus anticoagulant, specific factor inhibitors, and nonspecific inhibitors
ADNAS - Overview: Anti-DNase B Titer, Serum
Demonstration of acute or recent streptococcal infection using anti-DNase B titer
SASP - Overview: Aspergillus fumigatus, IgG Antibodies, Serum
Evaluation of patients suspected of having hypersensitivity pneumonitis (HP) induced by exposure to Aspergillus fumigatus Evaluation of patients suspected of having HP who have documented environmental exposures to high-humidity...
CRTFR - Overview: Creatinine, Random, Urine
Normalizing urinary analytes to account for the variation in urinary concentrations between individuals when using random urine collections
SFINC - Overview: Cerebrospinal Fluid (CSF) IgG Index, Spinal Fluid
Aiding in the diagnosis of multiple sclerosis and other central nervous system inflammatory conditions using cerebrospinal fluid specimens
CARNP - Overview: Carbapenemase Detection-Carba NP Test, Varies
Confirming carbapenemase production from pure isolates of Enterobacterales or Pseudomonas aeruginosa
CDTA - Overview: Carbohydrate Deficient Transferrin, Adult, Serum
Indicating chronic alcohol abuse This test is not appropriate for screening patients for congenital disorders of glycosylation.
CURCU - Overview: Copper/Creatinine Ratio, Random, Urine
Investigation of Wilson disease and obstructive liver disease using a random urine specimen
CURC - Overview: Copper/Creatinine Ratio, Urine
Measurement of copper concentration of a part of the investigation of Wilson disease and obstructive liver disease using a random urine specimen
CRCRU - Overview: Chromium/Creatinine Ratio, Random, Urine
Detecting chromium exposure
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Detection of (1→3)-𝝱-D-glucan as a Marker of Invasive Fungal Disease - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the detection of (1→3)-β-D-glucan (BDG) in serum as a biomarker for the presence of invasive fungal infections....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....